Go to the list of all blogs
published in Blogs
Jul 30, 2026
Morgan Stanley (MS) Posts Record Q2 2026 Earnings on Surging Trading and Banking Revenue

Morgan Stanley (MS) Posts Record Q2 2026 Earnings on Surging Trading and Banking Revenue

Key Takeaways

  • Record revenue and earnings: Morgan Stanley posted net revenues of $21.3 billion and diluted earnings per share (EPS) of $3.46 for the second quarter of 2026, both all-time highs that handily exceeded analyst consensus estimates.
  • Equities trading surged 69%: Equity sales and trading revenue reached a record $6.3 billion, driven by heightened client activity amid global market volatility, geopolitical tensions, and shifting interest rate expectations.
  • Investment banking rebounded powerfully: Investment banking revenue jumped 58% year over year to $2.44 billion, fueled by a boom in mergers and acquisitions (M&A) and blockbuster initial public offerings (IPOs), including the SpaceX debut.
  • Wealth Management hit a milestone: The division attracted a record $148 billion in net new assets, pushing combined client assets across Wealth and Investment Management past the $10 trillion mark for the first time.
  • Profitability metrics strengthened: Return on tangible common equity (ROTCE) — a key measure of a bank's profitability from its core operations — reached 26.6%, while the efficiency ratio improved to 65% from 71% a year earlier.
  • Share buyback fell short of some expectations: The firm repurchased $1.5 billion in shares, below one analyst estimate of $1.8 billion, which contributed to a muted initial stock reaction despite the blockbuster results.

Why These Results Matter in Today’s Market

Morgan Stanley’s second-quarter 2026 results arrived at a pivotal moment for global financial markets. The first half of 2026 saw M&A activity surge to $2.8 trillion — the strongest first-half total since LSEG began tracking records in 1980 — while equity markets remained buoyant despite ongoing geopolitical tensions, persistent inflation concerns, and a more hawkish Federal Reserve stance. For Morgan Stanley, this environment created a tailwind across all three of its major business lines: Institutional Securities, Wealth Management, and Investment Management. The report matters not only because it reflects the health of Wall Street’s core profit engines — trading and dealmaking — but also because it showcases how Morgan Stanley’s diversified model, combining high-octane capital markets with steady fee-based wealth management income, performs under real-world stress and opportunity. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Breaking Down the Reported Numbers

Morgan Stanley reported net revenues of $21.3 billion for the second quarter ended June 30, 2026, a 27% increase from $16.8 billion in the same period a year ago. This result crushed the consensus analyst estimate of approximately $19.6 billion. Net income applicable to Morgan Stanley came in at $5.58 billion, or $3.46 per diluted share, up sharply from $3.54 billion, or $2.13 per share, a year earlier. Analysts had forecast EPS of roughly $2.93 to $2.94, meaning the bank delivered an earnings beat of approximately 18%.

The Institutional Securities division was the standout performer, generating record quarterly revenue of $11 billion — a 44.7% year-over-year jump. Equities trading revenue alone soared 69% to $6.3 billion, as market volatility tied to the U.S.-Iran conflict, oil price swings, and shifting Federal Reserve policy expectations drove heavy client hedging and portfolio repositioning. Fixed income net revenue rose 13%. Investment banking revenue reached $2.44 billion, up 58%, with advisory fees climbing to $798 million and both equity and fixed income underwriting significantly exceeding forecasts. Morgan Stanley served as lead underwriter on SpaceX’s record IPO, advised Fertitta Entertainment on its $17.6 billion acquisition of Caesars Entertainment, and acted as joint book-running manager on Alphabet’s equity capital raise. From what I see, the equities trading surge stands out as a direct reflection of client demand in uncertain times.

Wealth Management generated $8.9 billion in revenue, up from $7.8 billion a year ago. Net new assets reached a record $148 billion, far outpacing analyst expectations of around $55 billion to $67 billion. Over half of those inflows came through IPO-related activity in the workplace services channel. Total client assets in the wealth division rose 25% to $8.08 trillion, and combined with Investment Management, total client assets crossed the $10 trillion milestone. The firm’s Common Equity Tier 1 (CET1) ratio — a measure of a bank’s core capital strength — held steady at 14.8%. Return on equity (ROE) reached 20.7%, and ROTCE hit 26.6%, both comfortably above consensus estimates.

How the Market Reacted

Despite the overwhelmingly strong headline numbers, Morgan Stanley shares initially dipped approximately 1.2% in pre-market trading on July 15 before recovering to close roughly 1% higher at around $229.94. The mixed intraday action reflected a classic “buy the rumor, sell the fact” dynamic: the stock had already rallied roughly 28.5% year-to-date heading into the report, and peer banks including Goldman Sachs and JPMorgan Chase had already posted similarly robust results the day prior, reducing the element of surprise. One specific point of investor scrutiny was the firm’s $1.5 billion in share repurchases during the quarter, which fell short of KBW analyst Chris McGratty’s $1.8 billion estimate. The board did raise the quarterly dividend to $1.15 per share and reauthorized a $20 billion repurchase program, but those moves were largely anticipated. The broader takeaway, however, was that execution was strong across the board, and analyst commentary remained broadly constructive following the call.

What to Watch in the Second Half

Looking ahead, Morgan Stanley enters the second half of 2026 with considerable momentum, but several factors will determine whether the record-setting pace can be sustained.

First, the investment banking pipeline remains robust. The M&A environment continues to benefit from improving CEO confidence, a relatively accommodative regulatory backdrop, and strong equity market valuations that encourage dealmaking. The IPO calendar, headlined by the SpaceX debut, suggests that equity underwriting fees could remain elevated, though activity levels are inherently unpredictable and sensitive to sudden shifts in market sentiment or geopolitical stability.

Second, trading revenues — which reached an all-time high this quarter — are by nature volatile. Continued geopolitical friction, persistent inflation readings, and any Federal Reserve policy surprises could sustain elevated trading volumes, but a sudden calm in markets would present a tough comparison for the Institutional Securities division in the quarters ahead. I’m watching this closely as a potential driver of near-term results.

Third, the Wealth Management business is increasingly becoming the firm’s anchor. With $148 billion in net new assets this quarter and total client assets now above $10 trillion, the division provides a growing base of recurring fee income that can buffer against capital markets cycles. Investors should monitor net new asset trends, loan growth, and deposit costs in this segment for signs of sustained momentum or emerging pressure.

Finally, capital allocation will remain under the microscope. The $20 billion buyback authorization provides ample runway, but the pace of actual repurchases relative to market expectations — and whether the firm deploys capital toward acquisitions, as CEO Ted Pick has indicated is possible under strict criteria — will be a key narrative. Cost discipline, reflected in the improved 65% efficiency ratio, will also be watched closely as the firm balances investment in growth with profitability targets.

Refining Research with AI Tools

In my regular analysis of earnings seasons, I turn to Tickeron’s AI Screener to quickly filter opportunities and compare names like Morgan Stanley against peers using technical indicators and AI signals. It helps surface ideas that align with broader sector trends without replacing traditional due diligence.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: MS

MS's Stochastic Oscillator is staying in oversold zone for 2 days

Be on the lookout for a price bounce soon.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MS advanced for three days, in of 357 cases, the price rose further within the following month. The odds of a continued upward trend are .

MS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 298 cases where MS Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for MS moved out of overbought territory on June 24, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 42 similar instances where the indicator moved out of overbought territory. In of the 42 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on July 23, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MS as a result. In of 71 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for MS turned negative on July 16, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at .

MS moved below its 50-day moving average on July 28, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 86, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. MS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.054) is normal, around the industry mean (4.050). P/E Ratio (16.408) is within average values for comparable stocks, (47.480). Projected Growth (PEG Ratio) (1.925) is also within normal values, averaging (1.678). Dividend Yield (0.020) settles around the average of (0.034) among similar stocks. P/S Ratio (4.396) is also within normal values, averaging (29.031).

Notable companies

The most notable companies in this group are Morgan Stanley (NYSE:MS), Goldman Sachs Group (NYSE:GS), Charles Schwab Corp (The) (NYSE:SCHW), Gold.com Inc. (NYSE:GOLD).

Industry description

These banks specialize in underwriting (helping companies with debt financing or equity issuances), IPOs, facilitating mergers and other corporate reorganizations and acting as a broker or financial advisor for institutions. They might also trade securities on their own accounts. Investment banks potentially thrive on expanding its network of clients, since that could help them increase profits. Goldman Sachs, Morgan Stanley and CME Group Inc are some of the largest investment banking companies.

Market Cap

The average market capitalization across the Investment Banks/Brokers Industry is 13.12B. The market cap for tickers in the group ranges from 13 to 928.5B. PKRSF holds the highest valuation in this group at 928.5B. The lowest valued company is BFCH at 13.

High and low price notable news

The average weekly price growth across all stocks in the Investment Banks/Brokers Industry was -7%. For the same Industry, the average monthly price growth was -8%, and the average quarterly price growth was -19%. ANY experienced the highest price growth at 26%, while VIP experienced the biggest fall at -34%.

Volume

The average weekly volume growth across all stocks in the Investment Banks/Brokers Industry was 12%. For the same stocks of the Industry, the average monthly volume growth was 2% and the average quarterly volume growth was -35%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 61
P/E Growth Rating: 71
Price Growth Rating: 62
SMR Rating: 76
Profit Risk Rating: 85
Seasonality Score: 17 (-100 ... +100)
View a ticker or compare two or three
MS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a provider of diversified financial services including brokerage, investment management and venture capital services

Industry InvestmentBanksBrokers

Profile
Details
Industry
Investment Banks Or Brokers
Address
1585 Broadway
Phone
+1 212 761-4000
Employees
80000
Web
https://www.morganstanley.com
Interact to see
Advertisement
The Travelers Companies, Inc.(TRV), a major player in the property and casualty insurance market, reported fourth-quarter 2025 results on January 21, 2026, closing out a year marked by underwriting discipline despite volatile weather activity and pricing pressures. The results underscore Travelers’ ability to generate strong profitability while navigating challenges in personal insurance lines and heightened catastrophe risk.
FingerMotion, Inc. (NASDAQ: FNGR) reported fiscal third-quarter 2026 results on January 15, 2026, triggering a sharp selloff as investors reacted to a steep revenue decline and widening losses. Shares fell roughly 32% following the release after the mobile services provider disclosed a 32% year-over-year drop in revenue and a net loss of $1.67 million for the quarter ended November 30, 2025.
CSX (NASDAQ: CSX) reports Q4 2025 earnings after market close on January 22, 2026, with consensus EPS ~$0.42 and revenue ~$3.57 billion. Union Pacific (NYSE: UNP) follows on January 27, with EPS expected near $2.89 and revenue around $6.15 billion. Norfolk Southern (NYSE: NSC) closes the week on January 29, with consensus EPS ~$2.77.
The SPDR S&P Aerospace & Defense ETF (XAR) has surged to a new 52-week high above $281 this week, climbing 21% month-to-date and 20% year-to-date through January 2026. The rally, driven by robust sector momentum and a clean technical breakout, is outpacing broader indices like the S&P 500. XAR’s equal-weighted structure amplifies gains from top aerospace and defense holdings in missiles, aircraft, and space systems, attracting significant trader and institutional attention amid heightened geopolitical tensions.
The iShares U.S. Aerospace & Defense ETF (ITA) continues to attract trader attention, building on a remarkable 47.7% gain in 2025 amid rising defense budgets and heightened global security concerns. The ETF is approaching all-time highs, with top holdings such as GE Aerospace and RTX Corporation driving the rally. Traders are adding positions on dips while monitoring confirmation above key resistance levels near recent peaks, anticipating a potential technical breakout.
Chevron’s upcoming Q4 report highlights its first full quarters integrating Hess, following record Q3 production of 4.1 million barrels of oil equivalent per day (MMboe/d). Comparing CVX with ExxonMobil and Shell provides insight into how each supermajor is navigating a volatile oil market with prices hovering below $60 per barrel.
SoFi Technologies is set to report Q4 and full-year 2025 earnings on January 30, 2026, closing out a pivotal year for the digital finance platform. With its fiscal year ending December 31, the report follows a strong Q3 that featured record net revenue of $962 million and member growth to 12.6 million, a 35% year-over-year increase.
ASML reported Q4 2025 net sales of $9.7 billion, gross margin of 52.2%, net income of $2.8 billion, and record net bookings of $13.2 billion, including $7.4 billion in EUV orders.
IDEXX Laboratories (IDXX) reports Q4 2025 earnings on February 2, 2026, with analysts expecting continued strength in recurring revenue from companion animal diagnostics. Danaher (DHR) reports on January 28, while Thermo Fisher Scientific (TMO) follows in early February, with both facing low-single-digit core growth expectations across life sciences and diagnostics.
NIO Inc. (NIO) produced its one-millionth vehicle this week at its Hefei facility, closing out a record 2025 delivery total of 326,028 units, up 46.9% year over year. The milestone, announced January 6, reflects accelerating demand for core models such as the ES8 SUV and newer brands ONVO and Firefly.
Faraday Future Intelligent Electric Inc. (FFAI) shares traded near $1.02 this week following announcements of a non-binding $10 million stock purchase term sheet with AIxCrypto (AIxC) and preparations for a Stockholders’ Day on January 7, 2026. Trading volume spiked amid broader EV volatility, highlighting investor attention on FFAI’s pivot toward AI-enhanced mobility and robotics.
BTQ Technologies Corp. (BTQ), formerly BTQQF, launched the Bitcoin Quantum testnet this week—the first quantum-safe Bitcoin fork, 17 years after Bitcoin’s genesis block. The move coincided with inclusion in the $524.5 million VanEck Quantum Computing UCITS ETF, boosting European investor visibility.
VEU targets large- and mid-cap ex-U.S. stocks with ~3,800 holdings. VXUS offers broad all-cap exposure, including ~8,600 stocks across small-, mid-, and large-cap companies.
Apple (AAPL) reports Q1 FY2026 earnings on January 29, with consensus revenue at $138.5B and EPS at $2.67, supported by strong demand for iPhone 17 models, higher average selling prices, and continued Services growth. Microsoft (MSFT) reports Q2 FY2026 on January 28, expecting $80.3B revenue and $3.91 EPS, driven by Azure AI adoption and enterprise cloud expansion, though elevated capex spending (~$35B/quarter) remains under scrutiny.
Visa Inc. (V), the global payments network leader, reports Q1 FY2026 earnings on January 29, 2026, for the period ending December 31, 2025. This marks the start of FY2026 following a strong FY2025, where net revenue reached $40 billion (+11%) and EPS climbed to $11.47 (+14%). Investors are watching closely for insights into consumer spending, cross-border travel recovery, and digital payment adoption.
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.